Filing Details
- Accession Number:
- 0001179110-17-009109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-15 16:43:36
- Reporting Period:
- 2017-06-13
- Filing Date:
- 2017-06-15
- Accepted Time:
- 2017-06-15 16:43:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1005201 | Depomed Inc | DEPO | Pharmaceutical Preparations (2834) | 943229046 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1529033 | M Thadd Vargas | C/O Depomed, Inc. 7999 Gateway Boulevard, Suite 300 Newark CA 94560 | Svp, Business Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-06-13 | 21,751 | $9.59 | 19,816 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-13 | 19,816 | $9.60 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-06-13 | 19,320 | $7.12 | 19,320 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-13 | 45,000 | $6.08 | 64,320 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-13 | 43,000 | $6.11 | 107,320 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-13 | 53,500 | $6.77 | 160,820 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-13 | 160,820 | $9.53 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock | Disposition | 2017-06-13 | 19,320 | $0.00 | 19,320 | $7.12 |
| Common Stock | Common Stock | Disposition | 2017-06-13 | 45,000 | $0.00 | 45,000 | $6.08 |
| Common Stock | Common Stock | Disposition | 2017-06-13 | 43,000 | $0.00 | 43,000 | $6.11 |
| Common Stock | Common Stock | Disposition | 2017-06-13 | 53,500 | $0.00 | 53,500 | $6.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-01-14 | No | 4 | M | Direct | |
| 0 | 2021-09-01 | No | 4 | M | Direct | |
| 0 | 2022-01-12 | No | 4 | M | Direct | |
| 0 | 2023-02-07 | No | 4 | M | Direct |
Footnotes
- Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.
- The price reported is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares at each price within the range set forth in this footnote.
- 19,320 stock options were granted on January 14, 2011 and were exercisable in 48 equal monthly installments.
- 45,000 stock options were granted on September 1, 2011 and were exercisable in 48 equal monthly installments.
- 43,000 stock options were granted on January 12, 2012 and were exercisable in 48 equal monthly installments.
- 53,500 stock options were granted on February 7, 2013 and were exercisable in 48 equal monthly installments.
Billionaire Hedge Funds
